Patent ID: 7888370

Claim:
An aqueous, preserved, multi-dose, topically administrable otic solution composition consisting essentially of a) 0.545% (w/v) moxifloxacin hydrochloride; b) 0.11% (w/v) dexamethasone sodium phosphate; c) 0.01% (w/v) edetate disodium; d) 0.5-0.75% (w/v) sodium chloride; e) 0.3% (w/v) boric acid; f) 0.01% (w/v) benzalkonium chloride; g) 0.05% (w/v) tyloxapol; h) NaOH or HCl in an amount sufficient to cause the composition to have a pH from 7.8-8.0; and i) water.